Abstract: Compositions that include at least one protein that activates a Toll-like Receptor and includes at least a portion of at least one Toll-like Receptor agonist and at least a portion of at least one papillomavirus suppressor binding protein, papillomavirus transforming protein and papillomavirus capsid protein can be employed in methods that stimulate an immune response in a subject, in particular, a protective immune response in a subject. Compositions can further include an adjuvant and a carrier protein.
Type:
Application
Filed:
August 20, 2013
Publication date:
December 12, 2013
Applicant:
Vaxlnnate Corporation
Inventors:
Valerian Nakaar, James W. Huleatt, Thomas J. Powell, Albert E. Price